在NSCLC中通过Palbociclib介导的PP5抑制增强放射治疗易感性
Chao-Yuan Huang1, Li-Ju Chen1, Grace Chen2
1Division of Radiation Oncology, Department of Oncology, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei 100229, Taiwan.
Biochimica et biophysica acta. Molecular cell research
|December 1, 2024
概括
向PP5通过增加DNA损伤和亡来增强非小细胞肺癌 (NSCLC) 的放射治疗. 这项研究确定PP5是抗辐射的关键因素,为NSCLC患者提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 放射治疗研究 放射治疗研究
背景情况:
- 放射治疗是非小细胞肺癌 (NSCLC) 的首要治疗方法,但放射电阻经常会损害其有效性.
- 确定改善辐射敏感性的分子标对于提高NSCLC患者的治疗和息结果至关重要.
研究的目的:
- 研究PP5在NSCLC电阻中的作用及其作为治疗点的潜力.
- 探索palbociclib影响NSCLC放射敏感性的机制,重点关注PP5和AMPK通路.
主要方法:
- 生物信息学分析以比较NSCLC和正常组织中的PP5表达.
- 卡普兰-梅尔生存分析以将PP5表达与患者生存相关联,特别是在接受放射治疗的人群中.
- 在体外实验中评估palbociclib,AMPK抑制剂和PP5激活剂对NSCLC细胞辐射敏感性,DNA损伤,亡和自的作用.
主要成果:
- 在NSCLC组织中,PP5表达显著更高,并且与接受放射治疗的患者的整体存活率较差相关.
- 帕尔博西克利布向PP5 (独立于CDK4/6) 并通过诱导持续的DNA损伤和激活AMPK,增强放射敏感性.
- 组合疗法的疗效取决于AMPK激活和PP5功能,导致亡而不是自.
结论:
- PP5是NSCLC中放射电阻的关键媒介,也是潜在的治疗点.
- 针对PP5,结合放射治疗和palbociclib,可以显著改善NSCLC的治疗结果.
- 这项研究为克服NSCLC中放射电阻的新型组合治疗策略提供了基础.
相关概念视频
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K


